01 14Stelara
02 2Stelara
Main Therapeutic Indication : Immunology
Currency : USD
2020 Revenue in Millions : 7,707
2019 Revenue in Millions : 6,361
Growth (%) : 21
Main Therapeutic Indication : Immunology
Currency : USD
2020 Revenue in Millions : 265
2019 Revenue in Millions : 230
Growth (%) : 15
Main Therapeutic Indication : Immunology
Currency : USD
2021 Revenue in Millions : 406
2020 Revenue in Millions : 262
Growth (%) : 67
Main Therapeutic Indication : Immunology
Currency : USD
2021 Revenue in Millions : 9,134
2020 Revenue in Millions : 7,707
Growth (%) : 19
Main Therapeutic Indication : Immunology
Currency : USD
2022 Revenue in Millions : 9,723
2021 Revenue in Millions : 9,134
Growth (%) : 6
Main Therapeutic Indication : Immunology
Currency : USD
2022 Revenue in Millions : 500
2021 Revenue in Millions : 435
Growth (%) : 15
Main Therapeutic Indication : Immunology
Currency : USD
2023 Revenue in Millions : 10,858
2022 Revenue in Millions : 9,723
Growth (%) : 12
Main Therapeutic Indication : Immunology
Currency : USD
2023 Revenue in Millions : 439
2022 Revenue in Millions : 500
Growth (%) : -1
Main Therapeutic Indication :
Currency : USD
2014 Revenue in Millions : 37.80%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Immunology
Currency : USD
2015 Revenue in Millions : 2,072
2014 Revenue in Millions : 2,474
Growth (%) : 19%
